LEADER 01129nam a2200349 i 4500 001 991001119899707536 005 20020507183626.0 008 960430s|||| us ||| | eng 020 $a0691081751 035 $ab10803658-39ule_inst 035 $aLE01307336$9ExL 040 $aDip.to Matematica$beng 082 0 $a519.2 084 $aAMS 00A30 084 $aAMS 60A05 100 1 $aShafer, Glenn$0283969 245 12$aA mathematical theory of evidence /$cGlenn Shafer 260 $aPrinceton, N.J. :$bPrinceton Univ. Press, 300 $axiii, 297 p. ;$c24 cm. 500 $aBibliography: p. 287-291. 500 $aIncludes index. 650 4$aAxioms 650 4$aEvidence 650 4$aMathematical statistics 650 4$aPhilosophy of mathematics 650 4$aProbabilities 907 $a.b10803658$b21-09-06$c28-06-02 912 $a991001119899707536 945 $aLE013 60A SHA11 (1976)$g1$i2013000046952$lle013$o-$pE0.00$q-$rl$s- $t0$u1$v0$w1$x0$y.i10908018$z28-06-02 996 $aMathematical theory of evidence$9925355 997 $aUNISALENTO 998 $ale013$b01-01-96$cm$da $e-$feng$gus $h2$i1 LEADER 05504nam 2200673Ia 450 001 9910784655303321 005 20200520144314.0 010 $a1-280-74694-7 010 $a9786610746941 010 $a0-08-046774-1 035 $a(CKB)1000000000364086 035 $a(EBL)283973 035 $a(OCoLC)476032318 035 $a(SSID)ssj0000141655 035 $a(PQKBManifestationID)11136185 035 $a(PQKBTitleCode)TC0000141655 035 $a(PQKBWorkID)10079802 035 $a(PQKB)11779635 035 $a(Au-PeEL)EBL283973 035 $a(CaPaEBR)ebr10158436 035 $a(CaONFJC)MIL74694 035 $a(MiAaPQ)EBC283973 035 $a(EXLCZ)991000000000364086 100 $a20051220d2007 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aDrugs and the future$b[electronic resource] $ebrain science, addiction and society /$fscientific coordinators, David Nutt ... [et al.] 210 $aLondon $cElsevier/Academic$dc2007 215 $a1 online resource (615 p.) 300 $aDescription based upon print version of record. 311 $a0-12-370624-6 320 $aIncludes bibliographical references and index. 327 $aFront cover; DRUGS AND THE FUTURE; Copyright page; Table of contents; Contributors; Foreword Drugs and the Future; Introduction; Acknowledgements; Chapter 1. Drugs Futures 2025; Chapter 2. Foresight; 1 INTRODUCTION; 2 WHAT IS FORESIGHT?; 3 WHAT APPROACH DID WE USE TO EXPLORE THE FUTURE OF DRUG USE?; 4 WHAT HAPPENS NEXT?; Chapter 3. Neuroscience of Drugs and Addiction; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 NEUROPSYCHOLOGY OF REINFORCEMENT LEARNING AND ADDICTION; 4 THE NEURAL SYSTEM BASIS OF REINFORCEMENT LEARNING: RELEVANCE TO NATURAL MOTIVATION AND DRUG ADDICTION; 5 NEUROBIOLOGY OF RELAPSE 327 $a6 NEUROADAPTATIONS - INTRACELLULAR CASCADES7 VULNERABILITY TO ADDICTION; 8 HARMS CAUSED BY DRUGS OF ABUSE; 9 DRUG ADDICTION: A SOCIAL COGNITIVE NEUROSCIENCE PERSPECTIVE; 10 THE MIND/BRAIN INTERFACE: NEUROBEHAVIOURAL ECONOMICS OF ADDICTION; 11 FUTURE IMPLICATIONS: NEW DRUGS, THEIR IMPACT AND MANAGEMENT; Chapter 4. Genomics; 1 EXECUTIVE SUMMARY; 2 GENES IN ACTION; 3 GENETIC ANALYSIS; 4 CURRENT STATE OF PLAY; 5 FUTURE DIRECTIONS IN RESEARCH; 6 THE IMPLICATIONS OF DEFINING GENETIC INFLUENCES IN DRUG USE FOR THE INDIVIDUAL AND SOCIETY; 7 THE BRAIN SCIENCE, ADDICTION AND DRUGS PROJECT QUESTIONS 327 $a8 CONCLUSIONSChapter 5. Experimental Psychology and Research into Brain Science, Addiction and Drugs; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 SCIENTIFIC BASIS OF DRUG ADDICTION; 4 CURRENT PSYCHOACTIVE SUBSTANCES - EFFECTS AND HARMS; 5 INTERVENTIONS AND MANAGEMENT; 6 VISIONS FOR THE FUTURE - FUTURE CAPABILITIES AND APPLICATIONS; 7 CONCLUSIONS; Chapter 6. Pharmacology and Treatments; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 CURRENT PSYCHOACTIVE DRUGS; 5 DRUG TREATMENTS FOR SUBSTANCE USE DISORDERS; 6 FUTURE PSYCHOACTIVE SUBSTANCES; 7 FUTURE THERAPEUTICS 327 $a8 CONTEXT OF FUTURE TREATMENTS9 PROSPECTS; 10 APPENDIX: ACRONYMS; Chapter 7. Psychological Treatments of Substance Misuse and Dependence; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 WHERE ARE WE NOW? THE CURRENT EVIDENCE BASE ON PSYCHOLOGICAL TREATMENTS; 4 PSYCHOLOGICAL TREATMENTS OF SUBSTANCE MISUSE AND DEPENDENCE: THE FUTURE?; 5 WHAT WILL BE THE DRUGS OF THE FUTURE?; 6 PSYCHOSOCIAL TREATMENTS OF THE FUTURE; 7 PREVENTION STRATEGIES IN THE FUTURE?; 8 CONCLUSIONS; Chapter 8. Cognition Enhancers; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 BASIS OF LEARNING AND MEMORY 327 $a5 CURRENT COGNITION ENHANCERS6 COGNITION ENHANCERS IN DEVELOPMENT; 7 FUTURE COGNITION ENHANCERS; 8 IMPLICATIONS; 9 CONCLUSIONS; Chapter 9. Neuroimaging; 1 EXECUTIVE SUMMARY; 2 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION: DEFINING PHARMACOLOGY AND CRAVING; 3 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION; 4 FUNCTIONAL NEUROIMAGING IN PRECLINICAL MODELS OF ADDICTION; 5 MOLECULAR IMAGING AND THE ROLE OF PET; 6 ADVANCES IN MRI/S TECHNOLOGY; 7 TRANSCRANIAL MAGNETIC STIMULATION; 8 FURTHER DEVELOPMENTS; Chapter 10. Drug Testing; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 TEST MATRICES 327 $a4 ANALYTICAL METHODS 330 $aThis book presents 13 reviews collected to present the new advances in all areas of addiction research, including knowledge gained from mapping the human genome, the improved understanding of brain pathways and functions that are stimulated by addictive drugs, experimental and clinical psychology approaches to addiction and treatment, as well as both ethical considerations and social policy. The book also includes chapters on the history of addictive substances and some personal narratives of addiction. Introduced by Sir David King, Science Advisory to the UK Government and head of the Office 606 $aDrug abuse 606 $aDrug abuse$xGovernment policy 606 $aDrug addicts$xPsychology 606 $aDrug addicts$xRehabilitation 615 0$aDrug abuse. 615 0$aDrug abuse$xGovernment policy. 615 0$aDrug addicts$xPsychology. 615 0$aDrug addicts$xRehabilitation. 676 $a362.29 701 $aNutt$b David J.$f1951-$0971935 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910784655303321 996 $aDrugs and the future$93722212 997 $aUNINA LEADER 03450nam 2200745Ia 450 001 9910154728703321 005 20200520144314.0 010 $a9786613810519 010 $a9781282232778 010 $a1282232770 010 $a9780889207271 010 $a0889207275 024 7 $a10.51644/9780889207271 035 $a(CKB)2430000000002570 035 $a(EBL)685734 035 $a(OCoLC)243565360 035 $a(SSID)ssj0000382521 035 $a(PQKBManifestationID)11230954 035 $a(PQKBTitleCode)TC0000382521 035 $a(PQKBWorkID)10395553 035 $a(PQKB)10008692 035 $a(CaPaEBR)402494 035 $a(CaBNvSL)rjv00101388 035 $a(MiAaPQ)EBC3246297 035 $a(MdBmJHUP)muse14416 035 $a(MiAaPQ)EBC685734 035 $a(VaAlCD)20.500.12592/sz7nf9 035 $a(schport)gibson_crkn/2009-12-01/2/402494 035 $a(DE-B1597)667740 035 $a(DE-B1597)9780889207271 035 $a(Perlego)1706467 035 $a(EXLCZ)992430000000002570 100 $a19881028d1988 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aSociety, the sacred, and scripture in ancient Judaism $ea sociology of knowledge /$fJack N. Lightstone 205 $a1st ed. 210 $aWaterloo, Ont., Canada $cPublished for the Canadian Corporation for Studies in Religion by Wilfrid Laurier University Press$d1988 215 $a1 online resource (143 p.) 225 1 $aStudies in Christianity and Judaism =$aEtudes sur le christianisme et le judasme ;$v3 300 $aIncludes index. 311 08$a9780889209756 311 08$a0889209758 320 $aIncludes bibliographical references (p. 107-120) and index. 327 $aCONTENTS; Preface; Transliterations; Chapter One: Introduction; Chapter Two: The ""Restoration"" Community and the ""Torah of Moses""; Chapter Three: Diaspora, Sources of the Sacred, and Torah as Holy Relic; Chapter Four: Earliest Rabbinic Circles, Mishnah, and Scripture as Closed System; Chapter Five: Talmudic Rabbinism, Midrash, and the Fragmentation of Scripture; Notes; Selected Bibliography and Abbreviations; General Subject Index 330 $aThis work explores the relationship between religion, social patterns, and the perception of the character of scripture in four modes of Ancient Judaism: (1) the Jerusalem community of the fifth to fourth centuries B.C.E. (ie, the Early Second Temple Period); (2) the Judaism of the Graeco-Roman Disapora down to the end of the fourth century of the Christian Era; (3) earliest rabbinic Judaism in the second century C.E> in the land of Israel; (4) Late Antique Talmudic Rabbinism, primarily inn Babylonia, down to the sixth century of the Christian Era. Lightstone attempts not only to describe 410 0$aStudies in Christianity and Judaism ;$v3. 606 $aRabbinical literature$xHistory and criticism 606 $aJudaism$xHistory$yTo 70 A.D 606 $aJudaism$xHistory$yTalmudic period, 10-425 615 0$aRabbinical literature$xHistory and criticism. 615 0$aJudaism$xHistory 615 0$aJudaism$xHistory 676 $a296.1/2067 700 $aLightstone$b Jack N$01102823 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910154728703321 996 $aSociety, the Sacred and Scripture in Ancient Judaism$92866850 997 $aUNINA